Investigational Drug Information for Elobixibat
What is the development status for investigational drug Elobixibat?
Elobixibat is an investigational drug.
There have been 13 clinical trials for Elobixibat.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2021.
The most common disease conditions in clinical trials are Constipation, Non-alcoholic Fatty Liver Disease, and Liver Diseases. The leading clinical trial sponsors are Ferring Pharmaceuticals, Yokohama City University, and Albireo.
There are two hundred and eighty US patents protecting this investigational drug and zero international patents.
Summary for Elobixibat
| US Patents | 280 |
| International Patents | 2,564 |
| US Patent Applications | 626 |
| WIPO Patent Applications | 195 |
| Japanese Patent Applications | 137 |
| Clinical Trial Progress | Phase 3 (2021-09-01) |
| Vendors | 42 |
Recent Clinical Trials for Elobixibat
| Title | Sponsor | Phase |
|---|---|---|
| Comparison of Bowel Preparation Using 2 Liter Polyethylene Glycol Regimen Plus Elobixibat Versus 4-Liter Polyethylene Glycol Regimen | Department of Medical Services Ministry of Public Health of Thailand | NA |
| Elobixibat for Chronic Constipation Without Defecation Desire | International University of Health and Welfare | Phase 4 |
| Elobixibat for Chronic Constipation Without Defecation Desire | Yokohama City University | Phase 4 |
Clinical Trial Summary for Elobixibat
Top disease conditions for Elobixibat
Top clinical trial sponsors for Elobixibat
US Patents for Elobixibat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Elobixibat | ⤷ Start Trial | IBAT inhibitors for the treatment of liver diseases | Albireo AB (Gothenburg, SE) | ⤷ Start Trial |
| Elobixibat | ⤷ Start Trial | IBAT inhibitors for the treatment of liver diseases | Albireo AB (Gothenburg, SE) | ⤷ Start Trial |
| Elobixibat | ⤷ Start Trial | Branched 3-phenylpropionic acid derivatives and their use | BAYER PHARMA AKTIENGESELLSCHAFT (Monheim, DE) | ⤷ Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Elobixibat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Elobixibat | Australia | AU2011326871 | 2030-11-08 | ⤷ Start Trial |
| Elobixibat | Brazil | BR112013010157 | 2030-11-08 | ⤷ Start Trial |
| Elobixibat | Canada | CA2815749 | 2030-11-08 | ⤷ Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
